DOCSLIB.ORG

Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome REVIEW ARTICLE Relationship Between Deep Venous Thrombosis and the Postthrombotic Syndrome Susan R. Kahn, MD, MSc, FRCPC; Jeffrey S. Ginsberg, MD, FRCPC he postthrombotic syndrome (PTS) is a frequent complication of deep venous thrombo- sis (DVT). Clinically, PTS is characterized by chronic, persistent pain, swelling, and other signs in the affected limb. Rarely, ulcers may develop. Because of its prevalence, severity, and chronicity, PTS is burdensome and costly. Preventing DVT with the use of effective Tthromboprophylaxis in high-risk patients and settings and minimizing the risk of ipsilateral DVT re- currence are likely to reduce the risk of development of PTS. Daily use of compression stockings after DVT might reduce the incidence and severity of PTS, but consistent and convincing data about their effectiveness are not available. Future research should focus on standardizing diagnostic criteria for PTS, identifying patients at high risk for PTS, and rigorously evaluating the role of thrombolysis in preventing PTS and of compression stockings in preventing and treating PTS. In addition, novel thera- pies should be sought and evaluated. Arch Intern Med. 2004;164:17-26 The postthrombotic syndrome (PTS) is a CLINICAL PRESENTATION AND chronic condition that develops in 20% to PATHOPHYSIOLOGY OF PTS 50% of patients within 1 to 2 years of symptomatic deep venous thrombosis Patients with PTS complain of pain, (DVT). A severe form, which can include heaviness, swelling, cramps, itching, or venous ulcers, occurs in one quarter to one tingling in the affected limb. Typically, third of patients with PTS.1,2 Because of its symptoms are aggravated by standing or prevalence and chronicity, PTS is costly walking and improve with rest and to society and is a cause of substantial pa- recumbency. On physical examination, tient morbidity. edema, telangiectasias, hyperpigmenta- In this article, we critically review the tion, eczema, and varicose collateral evidence informing current understand- veins are often present. In severe cases, ing of the pathophysiology, epidemiol- lipodermatosclerosis and ulceration may ogy, diagnosis, and management of PTS. result3-6 (Table 1). The burden of PTS from both a patient and The pathophysiology of PTS is in- a societal perspective is discussed. Using completely understood, but it is thought standard criteria to grade the quality of the that the acute thrombus itself, associated available evidence, we provide recommen- mediators of inflammation, and the pro- dations for the prevention and treatment cess of vein recanalization in the weeks af- of PTS. This article also acknowledges con- ter DVT induce damage to venous valves, troversies in the field and key areas of on- leading to valvular incompetence (reflux). going and future research. Valvular incompetence, persistent ve- nous obstruction, or both cause venous hy- 6-8 From the Department of Medicine, McGill University, Center for Clinical Epidemiology pertension, which leads to edema, tis- & Community Studies, Sir Mortimer B. Davis Jewish General Hospital, Montreal, sue hypoxia, and, in some cases, skin 6,7 Quebec (Dr Kahn); and Department of Medicine, McMaster University, McMaster ulceration. A number of clinical stud- University Medical Center, Hamilton, Ontario (Dr Ginsberg). The authors have no ies have suggested that valvular reflux in relevant financial interest in this article. the proximal veins, particularly the pop- (REPRINTED) ARCH INTERN MED/ VOL 164, JAN 12, 2004 WWW.ARCHINTERNMED.COM 17 ©2004 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 Asymptomatic DVT not be made in the absence of clini- Table 1. Clinical Features cal symptoms; while most patients of Postthrombotic Syndrome Whether asymptomatic DVT (ie, de- with symptomatic PTS have valvu- tected by routine screening) leads to lar incompetence, many with val- Leg Symptoms* Signs PTS is controversial. One study found vular incompetence do not have that the frequency of PTS 2 to 7 years PTS.43 Heaviness Edema afterhiporkneearthroplastywassimi- Three clinical scales for the di- Pain Telangiectasia 32,44,45 Swelling Venous ectasia larly low (approximately 5%) in pa- agnosis of PTS are available and Itching Varicose veins tients whose routine predischarge have been used in a number of clini- Cramps Venous dilation venogram showed proximal DVT, calf cal studies. They are presented in de- Paresthesia Hyperpigmentation DVT, or no DVT.32 All patients with tail in Table 2.32,44-46 Bursting pain Stasis dermatitis (eczema) DVT received 6 to 12 weeks of anti- Redness coagulanttherapy.Otherinvestigators IMPACT OF PTS Dependent cyanosis Lipodermatosclerosis have also found low rates of PTS af- 33,34 Healed ulcer ter asymptomatic DVT. Con- Population-Based Studies: Open ulcer versely, some groups have shown that Incidence and Prevalence asmanyas25%to33%ofpatientswith *Symptom pattern: worsened by activity, asymptomatic DVT develop PTS.35,36 The prevalence of PTS is influ- standing; improved by rest, recumbency. Differences in patient selection, study enced by the incidence of DVT. De- design, and definition of PTS may ex- spite advances in its prevention and plain these discrepant results, but if treatment, the annual incidence of liteal vein, is associated with clini- 9-13 confirmed, this would support the venous thromboembolism (VTE) cal manifestations of PTS. There- clinical relevance of asymptomatic (ie, DVT and pulmonary embo- fore, preventing valve damage and DVT in studies of thromboprophy- lism) has not decreased and is 1.0 reducing venous hypertension are laxis37 and would provide a rationale to 1.6 per 1000 persons per year, likely to be important in prevent- for reducing the risk of such with a per-person lifetime inci- ing PTS. thrombi.38,39 dence of 2% to 5%.47-51 Approxi- mately 250000 new cases of VTE oc- FACTORS THAT PREDICT Patient Characteristics cur in the United States each year.48 THE DEVELOPMENT OF PTS The population burden of PTS is dif- AFTER DVT In prospective studies, clinical fea- ficult to estimate because of vary- tures such as delay in initiating treat- ing definitions of PTS and a ten- Recurrent DVT ment for DVT; risk factors for throm- dency to undercode chronic bosis; family history of thrombosis; conditions. In a recent study, cu- The only clearly identified risk fac- protein C, protein S, or antithrom- mulative rates of venous stasis were tor for PTS is recurrent, ipsilateral bin deficiency; or the presence of the 7.3% at 1 year, 14.3% at 5 years, DVT, which increases the risk of PTS lupus anticoagulant have not been 19.7% at 10 years, and 26.8% at 20 1,14-17 found to increase the risk of devel- years after DVT; the cumulative risk as much as 6-fold. Recurrent 1,14 19 DVT probably causes additional oping PTS. In retrospective stud- of ulcer was 3.7% by 20 years. It damage to already compromised ve- ies, factors predictive of PTS were in- is estimated that more than one nous valves and further venous out- creasing age, female sex, hormone quarter of the at least 170000 new flow obstruction. therapy, varicose veins, abdominal cases of venous stasis syndrome per surgery, and increased body mass in- year represent PTS.52 40,41 Characteristics of dex. the Initial DVT Clinical Studies: DIAGNOSIS OF PTS Frequency of PTS After DVT There is little correlation between the There is no gold standard test for the The frequency of PTS after objec- venographic severity of the initial diagnosis of PTS. In patients with ob- tively diagnosed DVT is difficult to thrombus and subsequent develop- jectively confirmed DVT and a typi- estimate. Many studies have used ment of PTS.1,18 In some studies, the cal clinical presentation, PTS is usu- surrogate end points such as reflux risk of PTS was higher in patients ally the correct diagnosis. As it or abnormal results of venography with proximal rather than distal usually takes 3 to 6 months after without consideration of clinical (calf) DVT,19-22 while in others the acute DVT for the initial pain and symptoms and signs, and few have site of the initial thrombus did not swelling to resolve, a diagnosis of used validated PTS scores. influence the subsequent develop- PTS should be deferred until after Nonetheless, a few prospec- ment of PTS.1,18,23-25 In prospective this time. Objective evidence of ve- tive studies have provided key in- studies, reported rates of PTS after nous valvular incompetence by Dop- formation on the frequency of PTS distal DVT have ranged from 20% to pler ultrasound or by plethysmog- after symptomatic DVT. In a longi- 80%.25-31 Hence, calf DVT is associ- raphy helps to confirm the diagnosis tudinal cohort study of patients with ated with a significant risk of sub- in symptomatic patients.10,11,20,25,42 a first episode of acute symptom- sequent PTS. However, a diagnosis of PTS should atic DVT, Prandoni et al1 found that (REPRINTED) ARCH INTERN MED/ VOL 164, JAN 12, 2004 WWW.ARCHINTERNMED.COM 18 ©2004 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 Table 2. Clinical Scales for the Diagnosis of Postthrombotic Syndrome Developed Rates Test Specifically Severity PTS Scale Criteria Used to Diagnose PTS Characteristics for PTS of PTS Ginsberg et al32 Pain and swelling of limb of Ն1-mo duration, typical character (worse at end Not assessed Yes No of day or with prolonged sitting/standing, better after night’s rest and leg elevation) that occurs Ն6 mo after acute DVT and Objective evidence of valvular
Load more

Recommended publications
  • Complete Healing of Venous Leg Ulcer Using a Collagen Based Dressing a Case Report
    Case Report Journal of Surgical Techniques and Procedures Published: 30 Jul, 2018 Complete Healing of Venous Leg Ulcer Using a Collagen Based Dressing a Case Report Dumont Isabelle1#, Caillava Celine2#, Dupoiron Stephanie2, Guillemin Yannis2## and Gouze Jean Noel2*## 1Department of Foot and Ankle Surgery, Center of the Foot Ransart, Belgium 2Department of Research and Development, Genbiotech, France #Dumont Isabelle and Caillava Celine Contributed Equally to this Work ##Guillemin Yannis and Gouze Jean Noel are Co-senor Authors Abstract Venous Leg Ulceration (VLU) is a common pathology which affects patients at any age. Ulcers are characterized by long-term healing, pain and frequent recurrence despite adherence to standard of care resulting in time consuming and costly treatments. Here, the authors describe the case of a diabetic, 63 years old male suffering from venous insufficiency and presenting a distal leg ulcer. The ulcer was treated using GBT013 device, a new biocompatible and biodegradable tri-dimensional collagen based matrix. GBT013 seems to be well integrated to the healing tissues and well tolerated. No complication or pain was reported during treatment. Complete healing was obtained within 36 days with no recurrence to date despite a context of stasis dermatitis. Keywords: Venous leg ulcer; Collagen dressing; Tri-dimensional matrix; Wound healing Abbreviations DFU: Diabetic Foot Ulcer; VLU: Venous Leg Ulcer Introduction Venous Leg Ulcers (VLUs) are open lesions of the lower extremities caused by venous disease. OPEN ACCESS Risk factors include all factors susceptible to increase pressure within vessels (e.g., obesity, immobility, thrombosis, varicose veins, and trauma) [1-3]. They are more common in women *Correspondence: and older people and represent 60% to 80% of leg ulcers [4-7].
    [Show full text]
  • Clinical Manifestations and Management of Livedoid Vasculopathy
    Clinical Manifestations and Management of Livedoid Vasculopathy Elyse Julian, BS,* Tania Espinal, MBS,* Jacqueline Thomas, DO, FAOCD,** Nason Rouhizad, MS,* David Thomas, MD, JD, EdD*** *Medical Student, 4th year, Nova Southeastern University College of Osteopathic Medicine, Ft. Lauderdale, FL **Assistant Professor, Nova Southeastern University, Department of Dermatology, Ft. Lauderdale, FL ***Professor and Chairman of Surgery, Nova Southeastern University, Ft. Lauderdale, FL Abstract Livedoid vasculopathy (LV) is an extremely rare and distinct hyalinizing vascular disease affecting only one in 100,000 individuals per year.1,2 Formerly described by Feldaker in 1955 as livedo reticularis with summer ulcerations, LV is a unique non-inflammatory condition that manifests with thrombi formation and painful ulceration of the lower extremities.3 Clinically, the disease often displays a triad of livedo racemosa, slow-healing ulcerations, and atrophie blanche scarring.4 Although still not fully understood, the primary pathogenic mechanism is related to intraluminal thrombosis of the dermal microvessels causing occlusion and tissue hypoxia.4 We review a case in which the patient had LV undiagnosed and therefore inappropriately treated for more than 20 years. To reduce the current average five-year period from presentation to diagnosis, and to improve management options, we review the typical presentation, pathogenesis, histology, and treatment of LV.4 Upon physical exam, the patient was found to have the patient finally consented to biopsy. The ACase 62-year-old Report Caucasian male presented in an a wound on the right medial malleolus measuring pathology report identified ulceration with fibrin assisted living facility setting with chronic, right- 6.4 cm x 4.0 cm x 0.7 cm with moderate serous in vessel walls associated with stasis dermatitis lower-extremity ulcers present for more than 20 exudate, approximately 30% yellow necrosis characterized by thick-walled capillaries and years.
    [Show full text]
  • Outcome of Venous Stasis Ulceration When Complicated by Arterial Occlusive Disease
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Eur J Vasc Endovasc Surg 24, 249±254 (2002) doi:10.1053/ejvs.2002.1650, available online at http://www.idealibrary.com on Outcome of Venous Stasis Ulceration when Complicated by Arterial Occlusive Disease W. T. Bohannon, R. B. McLaffertyÃ, S. T. Chaney, M. A. Mattos, L. A. Gruneiro, D. E. Ramsey and K. J. Hodgson Division Vascular Surgery, Department of Surgery, Southern Illinois University, School of Medicine, Springfield, Illinois, U.S.A. Objective: to report the outcome of patients with venous stasis ulceration (VSU) and severe arterial occlusive disease (AOD). Design: retrospective study. Methods: using the International Classification of Diseases (ICD-9), codes for VSU and AOD were cross-matched to identify patients from 1989 to 1999 at two tertiary hospitals. Entry into the study required the presence of a VSU and an ipsilateral procedure to improve AOD or major amputation during the same hospitalisation. Results: fourteen patients (15 extremities) with a mean age of 80 years (range: 47±93) were identified as having VSU and AOD. Mean duration of VSU up to the time of revascularisation or amputation was 6.4 years (range: 4 months±21 years). The mean number of VSUs per extremity was 2.1 and mean wound area was 71 cm2. Mean ankle±brachial index was 0.46 (range: 0.10±0.78). Nine extremities (60%) had a bypass procedure, 3 (20%) had an interventional procedure, 1 (0.6%) had a lumbar sympathectomy, and 2 (13%) had an amputation.
    [Show full text]
  • Cutaneous Manifestations of Abdominal Arteriovenous Fistulas
    Cutaneous Manifestations of Abdominal Arteriovenous Fistulas Jessica Scruggs, MD; Daniel D. Bennett, MD Abdominal arteriovenous (A-V) fistulas may be edema.1-3 We report a case of abdominal aortocaval spontaneous or secondary to trauma. The clini- fistula presenting with lower extremity edema, ery- cal manifestations of abdominal A-V fistulas are thema, and cyanosis that had been previously diag- variable, but cutaneous findings are common and nosed as venous stasis dermatitis. may be suggestive of the diagnosis. Cutaneous physical examination findings consistent with Case Report abdominal A-V fistula include lower extremity A 51-year-old woman presented to the emergency edema with cyanosis, pulsatile varicose veins, department with worsening lower extremity swelling, and scrotal edema. redness, and pain. Her medical history included a We present a patient admitted to the hospital diagnosis of congestive heart failure, chronic obstruc- with lower extremity swelling, discoloration, and tive pulmonary disease, hepatitis C virus, tobacco pain, as well as renal insufficiency. During a prior abuse, and polysubstance dependence. Swelling, red- hospitalization she was diagnosed with venous ness, and pain of her legs developed several years stasis dermatitis; however, CUTISher physical examina- prior, and during a prior hospitalization she had been tion findings were not consistent with that diagno- diagnosed with chronic venous stasis dermatitis as sis. Imaging studies identified and characterized well as neurodermatitis. an abdominal aortocaval fistula. We propose that On admission, the patient had cool lower extremi- dermatologists add abdominal A-V fistula to the ties associated with discoloration and many crusted differential diagnosis of patients presenting with ulcerations. Aside from obesity, her abdominal exam- lower extremity edema with cyanosis, and we ination was unremarkable and no bruits were noted.
    [Show full text]
  • Doxium Has Been Proven to Be the Only Oral Agent Available for Delaying the Progression of Diabetic Retinopathy. It Has Also
    Doxium has been proven to be the only oral agent available for delaying the progression of diabetic retinopathy. It has also shown benefits in chronic venous insufficiency and haemorrhoids. Product Indications Pack Size DOXIUM 500 Cases of microangiopathy including diabetic retinopathy, 30’s/box capsules. chronic venous insufficiency. As an adjuvant in the treatment of blister-pack Each cap. contains superficial thrombophlebitis, post-thrombotic syndrome, 500mg calcium oedema, stasis dermatitis, circulatory disturbances of dobesilate. arteriovenous origin or due to impaired microcirculation & haemorrhoidal syndrome. ACTIVE PRINCIPLE Calcium 2, 5 dihydroxybenzenesulfonate (Ca dobesilate, INN) PROPERTIES Doxium corrects capillary hyperpermeability and increases capillary resistance. It antagonises the effect of vasoactive substances (histamine, serotonin, bradykinin, prostaglandins and PAF), acts against collagen breakdown, reduces blood hyperviscosity, increases red cell flexibility, diminishes platelet hyperaggregation and improves lymphatic drainage. CONTRA-INDICATIONS No contra-indications known up to now. TOLERABILITY Doxium is particularly well tolerated, even when administered for long-term therapy. It is not toxic; it is practically not metabolized in the body and does not impair hepatic or renal function in any way. It has no effect on arterial blood pressure, blood coagulation or glucose and lipid metabolisms. Doxium has no teratogenic effects and does not cross the placental barrier. Like most drugs, it should not be administered during the first 3 months of pregnancy. Numerous published clinical trials, totaling over 5000 cases, show that the incidence of undesirable side effects is extremely low (3.4%). These usually involve slight digestive disorders. PRESENTATIONS DOXIUM 500, capsules containing 500mg calcium dobesilate. .
    [Show full text]
  • Association Between Hemorrhoids and Lower Extremity Chronic Venous Insufficiency
    Open Access Original Article DOI: 10.7759/cureus.4502 Association Between Hemorrhoids and Lower Extremity Chronic Venous Insufficiency Ugur Ekici 1 , Abdulcabbar Kartal 2 , Murat F. Ferhatoglu 2 1. General Surgery, Istanbul Gelişim University, Istanbul, TUR 2. General Surgery, Okan University Medical Faculty, Istanbul, TUR Corresponding author: Abdulcabbar Kartal, [email protected] Disclosures can be found in Additional Information at the end of the article Abstract Aim The aim of the present study was to evaluate the incidence of varicose veins among patients with hemorrhoidal disease and to compare its incidence reported in various community-based studies. Method The study group comprised of 100 patients who underwent surgery for symptomatic internal or external hemorrhoids; the control group consisted of 100 volunteers who received no prior therapy for hemorrhoidal disease and lacked any symptoms or findings suggestive of this condition. Subjects in both the groups were inquired with respect to their demographic data and risk factors. Both groups were asked to stand for two minutes before performing leg examinations while still in the standing position. The findings were recorded for both the groups. Varicose veins were classified according to the clinical appearance section of the Clinical, Etiologic, Anatomic, and Pathophysiologic (CEAP) classification that was developed by the 1994 American Venous Forum. Results There was no significant difference between the two groups with respect to age and body mass index (BMI). Significant relationships were identified between the groups with respect to the incidence of varicose veins and chronic constipation. The incidence of C1 and C2 varicose veins observed in the study group was higher than that observed in the control group.
    [Show full text]
  • Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD)
    Evidence-based Practice Center Systematic Review Protocol Project Title: Treatment Strategies for Patients with Lower Extremity Chronic Venous Disease (LECVD) Project ID: DVTT0515 Initial publication date if applicable: March 7, 2016 Amendment Date(s) if applicable: May 6th, 2016 (Amendments Details–see Section VII) I. Background for the Systematic Review Lower extremity chronic venous disease (LECVD) is a heterogeneous term that encompasses a variety of conditions that are typically classified based on the CEAP classification, which defines LECVD based on Clinical, Etiologic, Anatomic, and Pathophysiologic parameters. This review will focus on treatment strategies for patients with LECVD, which will be defined as patients who have had signs or symptoms of LE venous disease for at least 3 months. Patients with LECVD can be asymptomatic or symptomatic, and they can exhibit a myriad of signs including varicose veins, telangiectasias, LE edema, skin changes, and/or ulceration. The etiology of chronic venous disease includes venous dilation, venous reflux, (venous) valvular incompetence, mechanical compression (e.g., May-Thurner syndrome), and post-thrombotic syndrome. Because severity of disease and treatment are influenced by anatomic segment, LECVD is also categorized by anatomy (iliofemoral vs. infrainguinal veins) and type of veins (superficial veins, perforating veins, and deep veins). Finally, the pathophysiology of LECVD is designated typically as due to the presence of venous reflux, thrombosis, and/or obstruction. LECVD is common
    [Show full text]
  • Original Article
    Original Article Is chronic venous ulcer curable? A sample survey of a plastic surgeon V. Alamelu Department of Plastic, Reconstructive and Faciomaxillary Surgery, Madras Medical College and Govt General Hospital, Chennai - 600 003; Sri Jayam Hospital, West Tambaram, Chennai - 600 045; K.J. Hospital and Research Foundation, Poonamallee High Road, Chennai - 600 084, India Address for correspondence: Dr. V. Alamelu, 23, Ramakrishnan Street, West Tambaram, Chennai-600 045, India. E-mail: [email protected] ABSTRACT Introduction: Venous ulcers of lower limbs are often chronic and non-healing, many a time neglected by patients and their treating physicians as these ulcers mostly do not lead to amputation as in gangrenous arterial ulcer and also cost much to complete the course of treatment and prevention of recurrence. Materials and Methods: One hundred and twenty two lower limb venous ulcers came up for treatment between May 2006 and April 2009. Only twenty nine cases completed the treatment. The main tool of investigation was the non invasive Duplex scan venography. Biopsy of the ulcer was done for staging the disease. Patients’ choice of treatment was always conservative and as out-patient instead of hospitalisation and surgery, which required a lot of motivation by the treating unit. Results: Out of twenty nine cases, ten cases were treated conservatively and seven (24.13%) healed well. Remaining nineteen cases were given surgical modality in which fifteen cases (51.74%) were successful. Only seven cases (24.13%) failed to heal. Compression stockings were advised to control oedema, varices and pain. Foot care, regular exercises and follow-up were stressed effectively.
    [Show full text]
  • Venous Ulcers: Diagnosis and Treatment
    Venous Ulcers: Diagnosis and Treatment Susan Bonkemeyer Millan, MD; Run Gan, MD; and Petra E. Townsend, MD University of Florida Health Wound Care and Hyperbaric Center and the University of Florida College of Medicine, Gainesville, Florida Venous ulcers are the most common type of chronic lower extremity ulcers, affecting 1% to 3% of the U.S. population. Venous hypertension as a result of venous reflux (incompetence) or obstruction is thought to be the primary underlying mechanism for venous ulcer formation. Risk factors for the development of venous ulcers include age 55 years or older, family history of chronic venous insufficiency, higher body mass index, history of pulmonary embolism or superficial/deep venous throm- bosis, lower extremity skeletal or joint disease, higher number of pregnancies, parental history of ankle ulcers, physical inactivity, history of ulcers, severe lipodermatosclerosis, and venous reflux in deep veins. Poor prognostic signs for heal- ing include ulcer duration longer than three months, initial ulcer length of 10 cm or more, presence of lower limb arterial disease, advanced age, and elevated body mass index. On physical examination, venous ulcers are generally irregular and shallow with well-defined borders and are often located over bony prominences. Signs of venous disease, such as varicose veins, edema, or venous dermatitis, may be present. Other associated findings include telangiectasias, corona phlebectatica, atrophie blanche, lipodermatosclerosis, and inverted champagne-bottle deformity of the lower leg. Chronic venous ulcers significantly impact quality of life. Severe complications include infection and malignant change. Current evidence supports treatment of venous ulcers with compression therapy, exercise, dressings, pentoxifylline, and tissue products.
    [Show full text]
  • Venous Ulcers October 1, 2020
    Leading the way. The Guide Wire NEWSLETTER • JULY 2020 VENOUS ULCERS weight of the blood presses distally, interstitial tissue spaces produces What is a venous ulcer? and the highest pressures generated a brawny, brownish pigmentation Venous ulcers are a consequence by this mechanism are expressed at often associated with venous of venous hypertension, usually the level of the ankle and foot. ulcers. This is due to haemosiderin caused by chronic deep or deposition caused by the breakdown “The second mechanism of venous 1 superficial venous insufficiency1. of the red blood cells , and is hypertension is dynamic. The predominantly seen in the medial Until recently, it was believed that anatomic angulation of superficial lower third of the calf. Pigmentation venous ulceration was primarily to deep perforating veins and their may be followed by an itching, due to deep venous insufficiency contained valves normally prevent weeping dermatitis, in turn, possibly following valve failure, (either compartmental pressure from being progressing to ulceration2. Ulceration primary valvular failure, or as a transmitted to subcutaneous tissue may be either spontaneous, or as a consequence of deep venous and skin. Failure of this mechanism result of minor trauma. Although the thrombosis causing damage to the allows intra-compartmental pathophysiology of the ulceration venous valve), or as a result of failure forces to be transmitted directly to is not clear, it appears to be related unsupported subcutaneous veins of the calf muscle pump. However, to an inflammatory reaction in the and dermal capillaries. There, the recent studies have suggested that tissue, fibrin cuffing and eventual effective vessels elongate, dilate 3 up to 57% of venous ulcers are due lipodermatosclerosis .
    [Show full text]
  • Budd-Chiari Syndrome Secondary to Catheter-Associated Inferior Vena
    CASE REPORT | RELATO DE CASO Budd-Chiari syndrome secondary to catheter-associated inferior vena cava thrombosis Síndrome de Budd-Chiari secundária a trombose de veia cava inferior associada a cateter Authors ABSTRACT RESUMO Gustavo N. Araujo 1 Luciane M. Restelatto 1 Introduction: Patients with chronic Introdução: Pacientes com doença renal crô- Carlos A. Prompt 1,2 kidney disease (CKD) are at increased nica (DRC) apresentam risco aumentado de Cristina Karohl 1,2 risk for thrombotic complications. The complicações trombóticas e o uso de cateter use of central venous catheters as dialysis venoso central para realização de hemodiáli- vascular access additionally increases se aumenta este risco. Nós descrevemos um 1 Hospital de Clínicas de this risk. We describe the first case of caso de síndrome de Budd-Chiari (SBC) cau- Porto Alegre. Budd-Chiari syndrome (BCS) secondary sado pelo mal posicionamento de um cateter 2 Universidade Federal do to central venous catheter misplacement de diálise em um paciente com DRC e, para Rio Grande do Sul. in a patient with CKD. Case report: A nosso conhecimento, este é o primeiro caso 30-year-old female patient with HIV/AIDS relatado na literatura. Caso clínico: Paciente and CKD on hemodialysis was admitted feminina, 30 anos, com diagnóstico de HIV/ to the emergency room for complaints of SIDA e DRC em hemodiálise foi admitida fever, prostration, and headache in the na emergência com queixas de febre, pros- last six days. She had a tunneled dialysis tração e cefaleia há 6 dias. Ela apresentava catheter placed at the left jugular vein. um cateter de diálise tunelizado implantado The diagnosis of BCS was established 7 dias antes na veia jugular esquerda.
    [Show full text]
  • Chronic Venous Ulcers: a Comparative Effectiveness Review of Treatment Modalities Comparative Effectiveness Review Number 127
    Comparative Effectiveness Review Number 127 Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities Comparative Effectiveness Review Number 127 Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2007-10061-I Prepared by: Johns Hopkins University Evidence-based Practice Center Baltimore, MD Investigators Jonathan Zenilman, M.D. M. Frances Valle, D.N.P., M.S. Mahmoud B. Malas, M.D., M.H.S. Nisa Maruthur, M.D., M.H.S. Umair Qazi, M.P.H. Yong Suh, M.B.A., M.Sc. Lisa M. Wilson, Sc.M. Elisabeth B. Haberl, B.A. Eric B. Bass, M.D., M.P.H. Gerald Lazarus, M.D. AHRQ Publication No. 13(14)-EHC121-EF December 2013 Erratum January 2014 This report is based on research conducted by the Johns Hopkins University Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2007-10061-I). The findings and conclusions in this document are those of the author(s), who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services.
    [Show full text]